Compare HCA Health Inc (HCA) vs S&P Global Inc (SPGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs S&P Global Inc — how do they compare? HCA Health Inc trades at $371.96 (market cap $82.17B), while S&P Global Inc trades at $437.02 (market cap $132.71B). The key difference: S&P Global Inc is the larger of the two by market cap, and S&P Global Inc pays the higher dividend (0.87%). Which is the better fit depends on your goals.
| HCA | SPGI | |
|---|---|---|
Market Cap | $82.17B | $132.71B |
Sector | Health | Financials |
52-Week High | $545.13 | $534.79 |
52-Week Low | $334.32 | $370.42 |
Enterprise Value | $131.08B | $144.68B |
Dividend Yield | 0.84% | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.
The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.
S&P Global (SPGI) trades at $449.75, down 0.24% on the day, with a bullish technical outlook and strong fundamentals. The stock shows robust profitability with a 30.36% net income margin and consistent revenue growth, reaching $15.34B in 2025. Recent corporate actions include the spinoff of Mobility Global, streamlining operations. Analyst consensus is strongly bullish with a $531.11 price target, and technical indicators signal a buy from moving averages despite overbought RSI levels.
The outlook for SPGI is positive, driven by margin expansion targets, AI-driven growth in API usage, and resilient recurring revenues. Key risks include high valuation multiples and sensitivity to debt issuance cycles. Investment opportunity lies in its market-leading position and strategic focus post-spinoff, though investors should monitor execution on growth initiatives and macroeconomic factors affecting capital markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About S&P Global Inc
S&P Global provides data and benchmarks to capital and commodity market participants. In 2021 and excluding IHS Markit, S&P Ratings was over 45% of the firm's revenue and over 55% of the firm's operating income. S&P Ratings is the largest credit rating agency in the world. The firm's other segments include Market Intelligence, Indices, and Platts. Market Intelligence provides desktop tools and other data solutions to investment banks, corporations, and other entities. Indices provides benchmarks for financial markets and is monetized through subscriptions, asset-based fees, and transaction-based royalties. Platts provides benchmarks to commodity markets, principally petroleum.
Read more on SPGI →
